Crenezumab
Modify Date: 2025-08-21 15:46:24
Crenezumab structure
|
Common Name | Crenezumab | ||
|---|---|---|---|---|
| CAS Number | 1095207-05-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CrenezumabCrenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research[1]. |
| Name | Crenezumab |
|---|
| Description | Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |